Patents Assigned to AbbView Biotherapeutics Inc.
  • Vectors and host cells comprising a modified SV40 promoter for protein expression
    Patent number: 10053720
    Abstract: The present disclosure is directed to expression vectors, comprising a weakened SV40 promoter, and recombinant mammalian cells capable of producing high levels of a polypeptide of interest, methods of generating and using such recombinant mammalian cells.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: August 21, 2018
    Assignee: AbbView Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, J. Yun Tso, Yimin He